# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-27T17:06:28.658956
**Route:** OpenRouter + LaTeX
**Paper Hash:** 92fba27ff5c4acf2
**Tokens:** 15845 in / 1200 out
**Response SHA256:** a7343e661d40b06e

---

FATAL ERROR 1: **Data–Design Alignment (post-treatment observations / identifiable effects)**
- **Location:** Section 4.2 “Callaway-Sant’Anna Estimates” (paragraph beginning “Panel B shows group-specific ATTs…”), plus Section 4.3 “Event Study”; Figures `fig2_event_study_se.pdf` and `fig3_event_study_emp.pdf` and the text describing “event times −5 to +3”.
- **Error:** You state you use Callaway–Sant’Anna with **not-yet-treated** units as controls, and you also state (correctly) that because the **2018 cohort is last treated**, post-treatment effects are only identifiable for calendar years **up to 2017** (since after 2018 there are no not-yet-treated units). But then you:
  - claim an event study estimated for event times **−5 to +3** (which, for the 2016 cohort, requires identifying effects through **2019**), and
  - discuss post-treatment event-time estimates like “event time 1”, and generally frame the design as using post-treatment data through **2019**.
  
  Under the design “not-yet-treated as controls” with last treatment in 2018, you **cannot** identify dynamic effects at horizons that require post-2017 comparisons using not-yet-treated controls. In short: the event-study horizon and parts of the post-period interpretation **cannot be true at the same time** as your stated control-group choice.
- **How to fix:**
  1. Decide which estimand/control group you are actually using for the event study and CS dynamics:
     - **Option A (consistent with current text):** Keep “not-yet-treated controls” and **truncate** all reported dynamic effects to the last identifiable calendar year (likely through **2017**). That means you cannot report event time +2/+3 for 2016-treated units, and you must redraw Figures 2–3 and revise the text (“−5 to +3”, interpretations of later post years, etc.).
     - **Option B:** If you want dynamics through 2019, you must change identification (e.g., allow **already-treated** units as controls in a particular estimator, or use an alternative approach with explicit assumptions), and then rewrite the CS description (“not-yet-treated controls”) and the interpretation accordingly. (Be careful: this is not just wording; it changes identification.)
  2. Make the “overall ATT” interpretation consistent with what periods are actually contributing (if only 2016–2017 post periods contribute, you must say so clearly and not imply coverage through 2019).

---

FATAL ERROR 2: **Internal Consistency (sample period / “post-treatment window to 2019” vs identifiable ATT)**
- **Location:** Introduction (paragraph: “We restrict the post-treatment window to 2019…”), Section 3 Sample (panel ends in 2019), and Section 4.2 where you say identifiable post-treatment ATTs are “limited… (i.e., through 2017)”.
- **Error:** The paper repeatedly frames the analysis as having a post-treatment window through **2019**, but your own identification discussion implies that, with not-yet-treated controls and universal treatment by 2018, the causal comparisons cannot generally use 2018–2019 as post periods (in CS group-time terms). This creates a direct contradiction in what readers will believe your design is leveraging.
- **How to fix:**
  - Either (i) revise the paper everywhere to accurately state that the CS design identifies effects only through the last year with not-yet-treated controls (likely **2017**), *or* (ii) change the estimator/control-group strategy so that 2018–2019 are legitimately used for identification, and update the methodological description accordingly.
  - In either case, ensure the event-study horizon, the “post window” language, and which years enter the ATT are all consistent.

---

ADVISOR VERDICT: FAIL